title: Fluorescent particles in the antibody solution result in false TF- and CD14-positive microparticles in flow cytometric analysis.
abstract: Tissue factor (TF)-positive microparticles (MPs) are highly procoagulant, and linked to thrombosis in sepsis and cancer. MP-associated TF may be assayed by immunological or functional methods. Several reports have demonstrated discrepancies between TF-protein and TF-activity, which have been explained by antibody binding to "encrypted" or degraded forms of inactive TF-protein. Our goal was to evaluate the possible interference of fluorescent antibody aggregates in solutions containing antibodies against TF and CD14 in flow cytometric analysis. Using monocyte-derived microparticles (MPs) released from human monocytes, incubated with or without lipopolysaccharides (LPS) in vitro, we measured MP-associated TF-protein (flow cytometry) and TF-activity (clot formation assay). MPs released from monocytes exposed to LPS (1 ng mL(-1) ) had ∼14 times higher TF-activity than MPs originated from monocytes exposed to only culture medium. However, using untreated anti-TF antibodies (American Diagnostica and BD) in the flow cytometric analysis, MPs released from unstimulated monocytes had a similar number of TF-positive events as MPs secernated from LPS-stimulated monocytes [∼45,000 events mL(-1) (American Diagnostica); ∼15,000 events mL(-1) (BD)]. These TF-positive events did not exert any TF-activity, and centrifugation (17,000g, 30 min, 4°C) of the antibody solutions prior to use effectively removed the interfering fluorescent events. Removal of fluorescent interference, probably in the form of fluorescent antibody aggregates, from the antibody solutions by centrifugation is essential to prevent the occurrence of false positive flow cytometric events. The events can be mistaken as MP-associated TF-protein, and interpreted as a discrepancy between TF-protein and TF-activity.
authors: Blood Cell Research Group, Section for Research, Department of Medical Biochemistry, Oslo University Hospital, Ullevål, Oslo, Norway. H.C.Aass@medisin.uio.no
authors: Hans Christian D
authors: HC
authors: Aass
authors: Reidun
authors: R
authors: Øvstebø
authors: Anne-Marie S
authors: AM
authors: Trøseid
authors: Peter
authors: P
authors: Kierulf
authors: Jens Petter
authors: JP
authors: Berg
authors: Carola Elisabeth
authors: CE
authors: Henriksson
mesh_terms: D015415:Biomarkers / Q000378:metabolism; D055252:Cell-Derived Microparticles / Q000737:chemistry* / Q000187:drug effects / Q000378:metabolism; D002478:Cells, Cultured; D003951:Diagnostic Errors; D005434:Flow Cytometry / Q000379:methods*; D005456:Fluorescent Dyes / Q000737:chemistry* / Q000378:metabolism; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism; D018950:Lipopolysaccharide Receptors / Q000378:metabolism; D008070:Lipopolysaccharides / Q000494:pharmacology; D009000:Monocytes / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism; D013925:Thromboplastin / Q000032:analysis* / Q000502:physiology
chemical_list: D015415:Biomarkers; D005456:Fluorescent Dyes; D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides; D013925:Thromboplastin